Patient shielding: The need for a European consensus statement

Contact shielding has been in widespread use for the last 60-70 years aiming to protect against genetic effects, cancer, and other detriment. Since 2012, studies have begun to appear in the literature that question the continued use of such shielding, especially when radiographic technology has changed so much over the intervening period This literature has culminated in several professional bodies such as the American Association of Physicists in Medicine (AAPM) and the British Institute of Radiology (BIR) issuing guidance and statements recommending against the continued routine use of patient contact shielding. Many professional societies have also endorsed these statements. National statements on the matter continue to be produced. It is notable however that the major European bodies involved in diagnostic radiology and radiation safety have not to date issued a statement on patient shielding. This commentary looks at reasons for that and argues that it is now time for a European consensus statement on patient shielding. It is the authors belief that there are advantages to building on the work done by the AAPM and BIR, using the opportunity to amplify the statements, propagate the intent of the original statements, refine the message to deal with questions that have arisen since their publication. A working group, Gonad and Patient Shielding (GAPS) has been formed by members from a) the European Federation of Organisations for Medical Physics (EFOMP), b) the Eurosafe Imaging initiative of the European Society of Radiology (ESR), c) the European Federation of Radiographers Societies (EFRS), d) EURADOS and e) the BIR to produce a joint statement on the proper application of patient shielding in diagnostic and interventional radiology.